Donor Adverse Reactions Severity Grading: Validating the Proposed Grading Tool is organized by American Association of Blood Banks (AABB) and will be held from Sep 05, 2019 - Jul 01, 2022. This CME Conference has been approved for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.
Transfusion Medicine (Hemovigilance)
CEOs, Director, Hospital Blood Banks, Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Physicians, Research Scientists, Resident/Fellow, Scientists, Students (MD, MT, SBB)
A consistent assessment of the severity of donor adverse reactions is critical for understanding their impact. It will also help your donor center engage in comparative trend analysis with other blood collections, both locally and globally. This program will include a review of the proposed severity grading of blood donor adverse event tools developed by the AABB Donor Hemovigilance Working Group. Preliminary results from the international validation study will be presented along with several case studies to help the audience evaluate the clinical validity and applicability of the severity grading.
After participating in this educational activity, participants should be able to:
• Define categories of severity.
• Describe the development and application of the Severity Assessment Tool for reaction classification.
• Discuss preliminary validation study results.
• Apply severity grading to various clinical scenarios through presented cases studies.
Quality Management, Medical Education